ADIPOQ and rheumatoid arthritis: Because of these dependencies, it was suggested that the differences between RA patients and healthy individuals with regard to the levels of HMW and globular adiponectin could be regarded as potential RA biomarkers to evaluate the early stages of disease progression [26,51,52].